(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.35%) $91.45
-1.73% $ 7.37
@ $8.06
Wydano: 14 vas. 2024 @ 22:17
Zwrot: -8.56%
Poprzedni sygnał: vas. 14 - 18:43
Poprzedni sygnał:
Zwrot: 0.62 %
Live Chart Being Loaded With Signals
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins...
Stats | |
---|---|
Dzisiejszy wolumen | 805 920 |
Średni wolumen | 872 014 |
Kapitalizacja rynkowa | 1.09B |
EPS | $0.320 ( 2024-04-30 ) |
Następna data zysków | ( $0.0400 ) 2024-06-05 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 17.14 |
ATR14 | $0.00900 (0.12%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-23 | Hulse William Frank Iv | Sell | 8 896 | Common Stock |
2024-04-08 | Hulse William Frank Iv | Sell | 8 896 | Common Stock |
2024-03-01 | Puhy Dorothy E | Buy | 0 | |
2024-03-01 | Olson Tiffany | Buy | 0 | |
2024-03-13 | Hulse William Frank Iv | Sell | 20 381 | Common Stock |
INSIDER POWER |
---|
97.68 |
Last 95 transactions |
Buy: 35 462 522 | Sell: 808 933 |
Wolumen Korelacja
MiMedx Group Inc Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
AEY | 0.884 |
LULU | 0.881 |
JOAN | 0.867 |
QH | 0.859 |
HUGE | 0.859 |
SBUX | 0.858 |
EZGO | 0.856 |
ALLR | 0.852 |
GOODM | 0.851 |
NVIV | 0.847 |
10 Najbardziej negatywne korelacje | |
---|---|
HPLTU | -0.9 |
USAP | -0.893 |
PFSW | -0.892 |
CENX | -0.89 |
PMGMU | -0.882 |
MU | -0.882 |
JNCE | -0.88 |
LABP | -0.879 |
IVCB | -0.879 |
QRHC | -0.878 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
MiMedx Group Inc Korelacja - Waluta/Towar
MiMedx Group Inc Finanse
Annual | 2023 |
Przychody: | $321.48M |
Zysk brutto: | $266.84M (83.01 %) |
EPS: | $0.400 |
FY | 2023 |
Przychody: | $321.48M |
Zysk brutto: | $266.84M (83.01 %) |
EPS: | $0.400 |
FY | 2022 |
Przychody: | $267.84M |
Zysk brutto: | $219.53M (81.96 %) |
EPS: | $-0.270 |
FY | 2021 |
Przychody: | $258.62M |
Zysk brutto: | $215.33M (83.26 %) |
EPS: | $-0.0932 |
Financial Reports:
No articles found.
MiMedx Group Inc
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its products include EpiFix, a semi-permeable protective barrier membrane product used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers; AmnioFix, a semi-permeable protective barrier allograft, which comprises dehydrated human amnion/chorion membrane for use in surgical recovery applications; EpiCord and AmnioCord are dehydrated human umbilical cord allografts that are used to provide a protective environment for the healing process, as well as used in the advanced wound care and surgical recovery applications; and AMNIOBURN a semi-permeable protective barrier allograft used in the treatment of partial-thickness and full-thickness burns, as well as lead product includes mdHACM, a micronized form of AMNIOFIX, supplied in powder form. The company's products have applications primarily in the areas of wound care, burn, surgical, and non-operative sports medicine sectors of healthcare. It also sells allografts for dental applications on an original equipment manufacturer basis. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. MiMedx Group, Inc. is headquartered in Marietta, Georgia.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej